Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0Q77 stock hub

LON/0Q77 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0Q77is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

60.4M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0Q77

In the news

Latest news · LON/0Q77

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROEn/a

P25 -54.2P50 2.1P75 13.7

ROICn/a

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0Q77 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

166

Groups with data

Currency

EUR

Showing 166 of 166 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	UK
Employees	36
Employees Change	-3%
Employees Change Percent	-7.69
Enterprise value	EUR 72.6M
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	FR0010557264
Last refreshed	2026-05-10
Market cap	EUR 60.4M
Price	EUR 0.98
Price currency	EUR
Rev Per Employee	24,453.81x
Sector	Healthcare
Sic	2834
Symbol	lon/0Q77
Website	https://www.ab-science.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-12.11%
EV Earnings	-9.91x
EV/FCF	-11.95x
EV/Sales	81.8x
FCF yield	-10.04%
P/B ratio	-2.58x
P/S ratio	68.64x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	90.75%
Gross Profit	EUR 798,904
Gross Profit Growth	-25.32%
Gross Profit Growth Q	-67.67%
Gross Profit Growth3 Y	16.66%
Gross Profit Growth5 Y	0.11%
Net Income	EUR -7.3M
Net Income Growth Years	8%
Pretax Margin	-831.45%
Profit Per Employee	EUR -203,321
ROA	-14.79
Roa5y	-33.31
ROCE	-184.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-24.6%
Cagr1y	-33.08%
Cagr3y	-45.35%
Cagr5y	-41.92%
EPS Growth Years	8
Revenue Growth	-5.08x
Revenue Growth Q	-8.04x
Revenue Growth Years	2x
Revenue Growth3 Y	1.92x
Revenue Growth5 Y	1.4x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.05
Assets	EUR 18.2M
Cash	EUR 4.3M
Current Assets	EUR 10.7M
Current Liabilities	EUR 15.9M
Debt	EUR 16.4M
Debt FCF	EUR -2.69
Equity	EUR -23.4M
Interest Coverage	-4.57
Liabilities	EUR 41.6M
Long Term Assets	EUR 7.5M
Long Term Liabilities	EUR 25.7M
Net Cash	EUR -12M
Net Cash By Market Cap	EUR -19.93
Tangible Book Value	EUR -24.4M
Tangible Book Value Per Share	EUR -0.37
WACC	9.94

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.67
Inventory Turnover	0.44
Net Working Capital	EUR -7M
Quick ratio	0.64
Working Capital	EUR -5.2M
Working Capital Turnover	EUR -0.19

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-9.43%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-94.06%
1Y total return	-33.06%
200-day SMA	1.29
3Y total return	-83.68%
50-day SMA	1.23
50-day SMA vs 200-day SMA	50under200
5Y total return	-93.39%
All Time High	21.43
All Time High Change	-95.43%
All Time High Date	2020-12-24
All Time Low	0.77
All Time Low Change	27.27%
All Time Low Date	2024-11-25
ATR	0.03
Beta	1.29
Ch YTD	-35.95
High	0.99
High52	1.72
High52 Date	2025-07-04
High52ch	-42.96%
Low	0.98
Low52	0.98
Low52 Date	2026-05-07
Low52ch	0%
Ma50ch	-20.39%
Price vs 200-day SMA	-23.79%
RSI	26.29
RSI Monthly	36.68
RSI Weekly	32.09
Sharpe ratio	-0.42x
Sortino ratio	-0.54
Total Return	-9.43%
Tr YTD	-35.95
Tr1m	-19.41%
Tr1w	-8.07%
Tr3m	-29.09%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -4.5M
Operating margin	-509.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	27,853,443%
Net Borrowing	-1,578,682.8
Shares Insiders	31.11%
Shares Institutions	0%
Shares Qo Q	6.32%
Shares Yo Y	9.43%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -8.6M
Average Volume	688.9x
Bv Per Share	-0.35
CAPEX	EUR -174,010
Ch10y	-94.06
Ch1m	-19.41
Ch1w	-8.07
Ch1y	-33.06
Ch3m	-29.09
Ch3y	-83.69
Ch5y	-93.39
Ch6m	-14.19
Change	-1.01%
Change From Open	-1.41
Close	0.99
Days Gap	0.4
Depreciation Amortization	452,411.6
Dollar Volume	435,198.4
Earnings Date	2026-05-13
EBIT	EUR -4.5M
EBITDA	EUR -4M
EPS	EUR -0.13
F Score	2
FCF	EUR -6.1M
FCF EV Yield	-8.36x
Financing CF	2,543,292
Fiscal Year End	December
Founded	2,001
Investing CF	-162,010
Is Primary Listing	0
Last Earnings Date	2025-09-30
Last Report Date	2025-06-30
Ma150	1.27
Ma150ch	-22.65%
Ma20	1.14
Ma20ch	-14.19%
Net CF	-3,517,921
Next Earnings Date	2026-05-13
Open	0.99
Position In Range	0
Ppne	944,614.6
Price Date	2026-05-07
Relative Volume	644.62x
Revenue	880,337x
SBC By Revenue	287.73x
Share Based Comp	2,533,006
Tr6m	-14.19%
Volume	444,080

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0Q77 pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0Q77 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0Q77?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.0%

Share of float held by funds and institutions

Insider ownership

+31.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+9.4%

Negative means the company is buying back shares.

Technical

LON/0Q77 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

26.3

Below 30: short-term oversold

Price vs 200-day MA

-23.8%

50/200-day relationship not available

Beta (5Y)

1.29

More volatile than the market

Sharpe ratio

-0.42

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0Q77

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0Q77 stock rating?

lon/0Q77 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0Q77 analysis?

The full report lives at /stocks/lon/0Q77/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0Q77?

The latest report frames lon/0Q77 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0Q77 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.